Business Standard

Saturday, December 21, 2024 | 06:55 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

MARKETS: Sensex ends volatile session 133 pts higher ahead of F&O expiry

All that happened in the markets today

Image SI Reporter New Delhi
MARKET LIVE: MARKETS, Sensex, Nifty, BSE, NSE, sgx nifty, covid-19, jspl

2:05 PM

Global Market Update | European stocks inch higher as AstraZeneca gains on UK vaccine approval

European stocks edged higher on Wednesday as Britain approved a COVID-19 vaccine developed by AstraZeneca and Oxford University, while bets of more U.S. fiscal aid and massive vaccination efforts spurred hopes of a strong global economic recovery next year.The pan-European STOXX 600 rose 0.1%, hovering near a 10-month high hit in the previous session. Most markets in the region were subdued due to thin volumes in a holiday-shortened week. The German DAX was flat, while French and Spanish stocks slipped 0.1% each. (Source: Reuters)
Germany, DAX

 
 
1:55 PM

BUZZING STOCK :: Jindal Stainless stock slips 3%

The Boards of Jindal Stainless Limited (JSL) and Jindal Stainless (Hisar) Limited (JSHL) today approved the merger of JSHL into JSL in a share swap ratio of 1:1.95. Post the merger, JSL will be the single listed entity on the stock exchanges with promoter holding at 57 per cent, and remaining 43 percent by the public.
 
1:36 PM

This pharma stock has zoomed 567% in 40 trading days post re-listing

Shares of Orchid Pharma were locked in upper circuit for the 40th straight trading day, up 5 per cent at Rs 120.13 on the BSE on Wednesday. The stock has zoomed 567 per cent from the level of Rs 18, since its relisting on November 3, 2020. Till 12:35 pm, a combined only 83 equity shares had changed hands and there were pending buy orders for 135,000 shares on the BSE and NSE, the exchange data shows. READ MORE

medicine, drugs, pharma

1:27 PM

Zydus Cadila receives DCGI nod for NAFLD drug in India

Drug firm Zydus Cadila on Wednesday said it has received approval from the Drug Controller General of India (DCGI) for Saroglitazar Mg, used for the treatment of non-alcoholic fatty liver disease (NAFLD), in the country. The Drug Controller General of India (DCGI) has approved the new drug application (NDA) for Saroglitazar Mg for the treatment of non-alcoholic fatty liver disease (NAFLD) in India, Zydus Cadila said in a regulatory filing. 
1:15 PM

NEWS ALERT | Cabinet briefing at 3 pm today

-- I&B Minister Prakash Javdekar, Oil Minister Dharmendra Pradhan, and DV Sadananda Gowda on cabinet meeting
1:07 PM

JMC Projects bags orders worth Rs 698 cr

JMC Projects on Wednesday said it has bagged orders worth Rs 698 crore in the domestic market. In a filing to the BSE, the company said it has won orders for building projects in South India worth Rs 698 crore. The company's CEO and Deputy Managing Director S K Tripathi said: "Our order inflows for the current year has crossed Rs 6,700 crore. We remain confident to achieve our targeted numbers for the financial year 2020-21." JMC Projects (India) is a subsidiary of Kalpataru Power Transmission. (Text Source: PTI)
 
1:06 PM

NEWS ALERT | Govt declares Sarda Energy successful bidder for Gare-Palma-IV/7 & Sahapur West coal mines

12:50 PM

Shares of Astrazeneca Pharma India jump over 3% on Covid vaccine approval in UK

12:46 PM

MARKET UPDATE:: Sensex at day's low

12:45 PM

NEWS FLASH :: Oxford University/Astrazeneca vaccine authorised by UK

Coronavirus, vaccine, covid, drugs, clinical trials
12:40 PM

NEWS FLASH :: Maharashtra govt extends lockdown restrictions in the state till 31st January 2021

Mumbai Police
12:39 PM

Voda Idea, HDFC Bank, Britannia: Stocks that can give 30% return in 2021

HDFC Bank Limited (HDFCBANK): After crossing the significant resistance in the range of Rs 1,300 to Rs 1,350 levels, the counter is set to rise towards Rs 2,000 levels from a medium-term perspective. The current levels are indicating a consolidation in the range of Rs 1,350 to Rs 1,470 levels. The underneath trend exhibits an upside bias that may trigger a strong move. One can see the sluggish move on the volume structure, yet the stock is not showing weakness rather attempting to scale higher, this scenario indeed reflects a firm strength of the counter, as per the weekly chart. READ MORE
Budget2018

12:29 PM

Icra upgrades financial ratings of Tata Consumer Products to 'AAA'

ICRA has upgraded the rating for long-term financial instruments of Tata Consumer Products worth Rs 350 crore to AAA with a stable outlook from AA-plus. At the same time, it reaffirmed the rating for short-term instruments worth Rs 715 crore at A1-plus. ICRA also upgraded the company's fund-based working capital facilities at AAA with a stable outlook from AA-plus earlier. READ MORE
tata global beverages

12:17 PM

Praj Industries soars 5%; Cabinet likely to discuss Ethanol Production, says report

Union Cabinet is likely to take up matter on Ethanol procurement from grains; Govt may also consider extension of Ethanol production, according to a report
 
12:00 PM

SAIL hits 2-year high, zooms 100% in 2 months on strong earnings outlook

Shares of Steel Authority of India (SAIL) rose 5 per cent to hit an over two-year high of Rs 67.85 on the BSE in Wednesday's session amid expectations of further improvement in performance due to the realisation of uptick in the domestic market and progressively lower proportion of exports. The stock of the state-owned company was trading at its highest level since November 2018. Analysts at Edelweiss Broking expect SAIL’s performance to improve further driven by realisation uptick, volume growth and iron ore sales providing additional revenue stream. READ MORE

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 30 2020 | 7:53 AM IST